array:23 [
  "pii" => "S217357271100004X"
  "issn" => "21735727"
  "doi" => "10.1016/j.medine.2011.01.002"
  "estado" => "S300"
  "fechaPublicacion" => "2011-06-01"
  "aid" => "261"
  "copyright" => "Elsevier España, S.L. and SEMICYUC"
  "copyrightAnyo" => "2011"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "sco"
  "cita" => "Med Intensiva. 2011;35:286-7"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3320
    "formatos" => array:3 [
      "EPUB" => 150
      "HTML" => 2299
      "PDF" => 871
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2173572711000087"
    "issn" => "21735727"
    "doi" => "10.1016/j.medine.2010.11.001"
    "estado" => "S300"
    "fechaPublicacion" => "2011-06-01"
    "aid" => "235"
    "copyright" => "Elsevier España, S.L. and SEMICYUC"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "ssu"
    "cita" => "Med Intensiva. 2011;35:288-98"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 28492
      "formatos" => array:3 [
        "EPUB" => 199
        "HTML" => 23310
        "PDF" => 4983
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
      "titulo" => "Invasive Mechanical Ventilation in COPD and Asthma"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "288"
          "paginaFinal" => "298"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Ventilaci&#243;n mec&#225;nica invasiva en EPOC y asma"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1458
              "Ancho" => 1674
              "Tamanyo" => 76926
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Occlusion of the expiratory valve&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Garc&#237;a Vicente, J&#46;C&#46; Sandoval Almengor, L&#46;A&#46; D&#237;az Caballero, J&#46;C&#46; Salgado Campo"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Garc&#237;a Vicente"
            ]
            1 => array:2 [
              "nombre" => "J&#46;C&#46;"
              "apellidos" => "Sandoval Almengor"
            ]
            2 => array:2 [
              "nombre" => "L&#46;A&#46;"
              "apellidos" => "D&#237;az Caballero"
            ]
            3 => array:2 [
              "nombre" => "J&#46;C&#46;"
              "apellidos" => "Salgado Campo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572711000087?idApp=WMIE"
    "url" => "/21735727/0000003500000005/v2_201212101038/S2173572711000087/v2_201212101038/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S2173572711000063"
    "issn" => "21735727"
    "doi" => "10.1016/j.medine.2011.03.002"
    "estado" => "S300"
    "fechaPublicacion" => "2011-06-01"
    "aid" => "279"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and SEMICYUC"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Med Intensiva. 2011;35:280-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2482
      "formatos" => array:3 [
        "EPUB" => 125
        "HTML" => 1655
        "PDF" => 702
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Prediction of the Clinical Usefulness of Routine Chest X-rays in a Traumatology ICU"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "280"
          "paginaFinal" => "285"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Predicci&#243;n de la utilidad cl&#237;nica de la radiograf&#237;a de t&#243;rax rutinaria en una unidad de cuidados intensivos de traumatolog&#237;a"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; Chico Fern&#225;ndez, A&#46; Mohedano G&#243;mez, C&#46; Garc&#237;a-Fuentes, P&#46; Rico Cepeda, A&#46; Bueno Gonz&#225;lez, E&#46; Alted L&#243;pez"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Chico Fern&#225;ndez"
            ]
            1 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Mohedano G&#243;mez"
            ]
            2 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Garc&#237;a-Fuentes"
            ]
            3 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Rico Cepeda"
            ]
            4 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Bueno Gonz&#225;lez"
            ]
            5 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Alted L&#243;pez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572711000063?idApp=WMIE"
    "url" => "/21735727/0000003500000005/v2_201212101038/S2173572711000063/v2_201212101038/en/main.assets"
  ]
  "en" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Point of view</span>"
    "titulo" => "Tranexamic Acid Therapy Decreases Mortality of Traumatic Hemorrhagic Shock"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "286"
        "paginaFinal" => "287"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "A&#46; Mu&#241;oz-S&#225;nchez, F&#46; Murillo-Cabezas"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "A&#46;"
            "apellidos" => "Mu&#241;oz-S&#225;nchez"
            "email" => array:1 [
              0 => "angeles&#46;munoz&#46;sspa&#64;juntadeandalucia&#46;es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">¿</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "F&#46;"
            "apellidos" => "Murillo-Cabezas"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Cuidados Cr&#237;ticos y Urgencias&#44; Hospital Universitario Virgen del Roc&#237;o&#44; Sevilla&#44; Spain"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "El &#225;cido tranex&#225;mico disminuye la mortalidad del <span class="elsevierStyleItalic">shock</span> hemorr&#225;gico traum&#225;tico"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">The Lancet</span><a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> recently published a randomized&#44; controlled clinical trial&#44; which in our view may change the outcome of a serious condition&#58; traumatic hemorrhagic shock&#46; This was a high quality trial&#44; and thus contributed top class evidence&#46; The study was not characterized by commercial interests&#44; and the inclusion criteria were based on clinical judgments&#44; i&#46;e&#46;&#44; it offered maximum external validity&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The investigators&#44; under the name CRASH 2 Trial Collaborators&#44; came from 274 hospitals in 40 countries&#44; and were able to complete an ambitious project involving the recruitment of about 20&#44;000 trauma patients &#40;specifically 20&#44;211&#41; with significant blood losses&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">The study compared the use of a low-cost antifibrinolytic agent &#40;tranexamic acid&#41; versus placebo&#44; in the context of a double-blind design&#46; The drug was administered early&#44; in the first 8<span class="elsevierStyleHsp" style=""></span>h after trauma&#44; at a dosage of 2<span class="elsevierStyleHsp" style=""></span>g via the intravenous route&#44; a 1<span class="elsevierStyleHsp" style=""></span>g bolus initially&#44; and 1<span class="elsevierStyleHsp" style=""></span>g in perfusion over 8<span class="elsevierStyleHsp" style=""></span>h&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The trial methodology had been previously published in <span class="elsevierStyleItalic">The Lancet</span>&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> The primary endpoint was mortality of any cause during the first four weeks&#46; The losses during follow-up were minimal&#58; 33 patients in the active treatment group and 47 in the placebo arm&#46; The statistical analysis was carried out on an intention to treat &#40;ITT&#41; basis&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Global mortality&#44; not the only mortality associated to bleeding&#44; was significantly lowered in the tranexamic acid group &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;0035&#41;&#46; The incidence of occlusive vascular events&#44; fatal or otherwise&#44; was similar in both groups &#40;placebo and tranexamic acid&#41;&#46; Surprisingly&#44; no significant difference was recorded in the number of red cell concentrate units transfused in either group&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">Since the two study arms proved homogeneous in that they were balanced for multiple clinical risk parameters &#40;age&#44; gender&#44; time from trauma&#44; type of trauma&#44; systolic blood pressure upon admission&#44; respiratory frequency&#44; capillary filling time&#44; heart rate and level of consciousness according to the Glasgow coma scale&#41;&#44; and the breaches in protocol were identical in each arm &#40;0&#46;4&#37;&#41;&#44; the early administration of tranexamic acid was identified as a first-order therapeutic option thanks to its impact upon the most relevant medical variable&#58; patient mortality&#46; In addition&#44; given the low cost of tranexamic acid&#44; the use of only 81&#46;6 euros in treating 68 patients would allow the avoidance of one death in this group of patients&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">The study has some limitations&#8212;the most important being the fact that the trial does not clarify the mechanism by which tranexamic acid reduces mortality among patients with traumatic hemorrhage&#46; In fact&#44; not only bleeding-dependent mortality decreases&#44; but also global mortality among the trauma patients&#46; Thus&#44; the comment accompanying the article<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> suggests that a plasmin-mediated antiinflammatory effect may be involved&#46; A second study limitation would be the fact that the posology had not been previously tested in a phase II setting with this particular treatment indication&#46; In any case&#44; the dosage employed was consistent with the specifications of the Summary of Product Characteristics&#44; and with the data obtained from studies in heart surgery and other indications&#44; where no increased effectiveness was observed with higher doses&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Some years ago&#44; in this same journal&#44; we asked ourselves what could be done to improve the results obtained in serious trauma cases&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> At the time we did not suspect that an old drug such as tranexamic acid&#8211;with an accessible price anywhere in the world&#8211;could offer a positive response in the arduous attempt to lessen mortality among such patients&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">In conclusion&#44; given the results obtained&#44; the large number of traumatic bleeding deaths recorded worldwide&#44; and the efficiency of tranexamic acid&#44; we have supported the application to include this drug in the list of essential medicines of the World Health Organization &#40;WHO&#41;&#46; In our setting&#44; and from June 2010&#44; the Drug Commission has authorized the compassionate use of tranexamic acid in traumatic hemorrhagic shock patients treated in our hospital&#46; Until the drug company includes this treatment indication in the Summary of Product Characteristics&#44; we consider compassionate use to be the fastest way to make this drug available to patients with a view to improving the outcome of trauma cases involving significant blood losses&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflicts of Interest</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:6 [
        0 => array:2 [
          "identificador" => "xres9181"
          "titulo" => "Abstract"
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec10621"
          "titulo" => "Keywords"
        ]
        2 => array:2 [
          "identificador" => "xres9180"
          "titulo" => "Resumen"
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec10620"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflicts of Interest"
        ]
        5 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2011-01-13"
    "fechaAceptado" => "2011-01-18"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec10621"
          "palabras" => array:3 [
            0 => "Tranexamic acid"
            1 => "Traumatism"
            2 => "Traumatic bleeding shock"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec10620"
          "palabras" => array:3 [
            0 => "&#193;cido tranex&#225;mico"
            1 => "Traumatismo"
            2 => "<span class="elsevierStyleItalic">Shock</span> hemorr&#225;gico traum&#225;tico"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The CRASH 2&#44; a randomized&#44; double-blind&#44; controlled trial that enrolled 20&#44;211 adult trauma patients&#44; has shown that the administration of tranexamic acid significantly reduces all-cause mortality and that specifically associated with severe blood loss as well&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We consider it as a significant therapeutic advance&#44; because&#44; for the first time&#44; a drug has been demonstrated to safely diminish mortality due to traumatic bleeding shock&#46; On the basis of these results and the high rate of death due to traumatic bleeding&#44; we suggest that tranexamic acid should be considered for compassionate use in bleeding trauma patients prior to its definitive approval for this medical condition&#46;</p>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Un estudio aleatorizado&#44; controlado con placebo y doble ciego&#44; el CRASH 2&#44; ha concluido&#44; tras incluir a 20&#46;211 traumatizados&#44; que el &#225;cido tranex&#225;mico reduce significativamente la mortalidad&#44; tanto la global como la espec&#237;ficamente ligada a la perdida sangu&#237;nea severa&#46;</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Consideramos que este es un avance terap&#233;utico significativo&#44; ya que por primera vez un f&#225;rmaco se ha mostrado capaz de disminuir la letalidad del <span class="elsevierStyleItalic">shock</span> hemorr&#225;gico traum&#225;tico&#46; Dados los resultados&#44; el elevado volumen de muertes por sangrado traum&#225;tico que se producen en el mundo y la eficiencia del tranex&#225;mico&#44; proponemos su uso compasivo hasta la inclusi&#243;n de esta indicaci&#243;n en la ficha t&#233;cnica&#46;</p>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara">Please cite this article as&#58; Mu&#241;oz-S&#225;nchez A&#44; Murillo-Cabezas F&#46; El &#225;cido tranex&#225;mico disminuye la mortalidad del <span class="elsevierStyleItalic">shock</span> hemorr&#225;gico traum&#225;tico&#46; Med Intensiva&#46; 2011&#59;35&#58;286&#8211;7&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:4 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of tranex&#225;mico acid on death&#44; vascular occlusive events&#44; and blood transfusion in trauma patients with significant haemorrhage &#40;CRASH-2&#41;&#58; a randomised&#44; placebo-controlled trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "CRASH 2 Trial Collaborators"
                          "etal" => true
                          "autores" => array:3 [
                            0 => "H&#46; Shakur"
                            1 => "I&#46; Roberts"
                            2 => "R&#46; Bautista"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)60835-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2010"
                        "volumen" => "376"
                        "paginaInicial" => "23"
                        "paginaFinal" => "32"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20554319"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "CRASH2 Protocol&#46; 2005&#46; Available from&#58; <a class="elsevierStyleInterRef" href="http://www.thelancet.com/protocol-reviews/05PRT-1">http&#58;&#47;&#47;www&#46;thelancet&#46;com&#47;protocol-reviews&#47;05PRT-1</a>&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antifibrinolytic therapy&#58; new data and new concepts"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46;H&#46; Levy"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)60939-7"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2010"
                        "volumen" => "376"
                        "paginaInicial" => "3"
                        "paginaFinal" => "4"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20554318"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Qu&#233; podr&#237;amos hacer para mejorar los resultados en el traumatizado grave&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "F&#46; Murillo-Cabezas"
                            1 => "M&#46;A&#46; Mu&#241;oz-S&#225;nchez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Intensiva"
                        "fecha" => "2003"
                        "volumen" => "27"
                        "paginaInicial" => "669"
                        "paginaFinal" => "672"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735727/0000003500000005/v2_201212101038/S217357271100004X/v2_201212101038/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "402"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Point of view"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735727/0000003500000005/v2_201212101038/S217357271100004X/v2_201212101038/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357271100004X?idApp=WMIE"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Point of view
Tranexamic Acid Therapy Decreases Mortality of Traumatic Hemorrhagic Shock
El ácido tranexámico disminuye la mortalidad del shock hemorrágico traumático
A. Muñoz-Sánchez
Corresponding author
, F. Murillo-Cabezas
Cuidados Críticos y Urgencias, Hospital Universitario Virgen del Rocío, Sevilla, Spain
Read
1522
Times
was read the article
717
Total PDF
805
Total HTML
Share statistics
 array:23 [
  "pii" => "S217357271100004X"
  "issn" => "21735727"
  "doi" => "10.1016/j.medine.2011.01.002"
  "estado" => "S300"
  "fechaPublicacion" => "2011-06-01"
  "aid" => "261"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and SEMICYUC"
  "copyrightAnyo" => "2011"
  "documento" => "article"
  "crossmark" => 0
  "subdocumento" => "sco"
  "cita" => "Med Intensiva. 2011;35:286-7"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 3320
    "formatos" => array:3 [
      "EPUB" => 150
      "HTML" => 2299
      "PDF" => 871
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2173572711000087"
    "issn" => "21735727"
    "doi" => "10.1016/j.medine.2010.11.001"
    "estado" => "S300"
    "fechaPublicacion" => "2011-06-01"
    "aid" => "235"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and SEMICYUC"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "ssu"
    "cita" => "Med Intensiva. 2011;35:288-98"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 28492
      "formatos" => array:3 [
        "EPUB" => 199
        "HTML" => 23310
        "PDF" => 4983
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Review</span>"
      "titulo" => "Invasive Mechanical Ventilation in COPD and Asthma"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "288"
          "paginaFinal" => "298"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Ventilaci&#243;n mec&#225;nica invasiva en EPOC y asma"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1458
              "Ancho" => 1674
              "Tamanyo" => 76926
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Occlusion of the expiratory valve&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Garc&#237;a Vicente, J&#46;C&#46; Sandoval Almengor, L&#46;A&#46; D&#237;az Caballero, J&#46;C&#46; Salgado Campo"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Garc&#237;a Vicente"
            ]
            1 => array:2 [
              "nombre" => "J&#46;C&#46;"
              "apellidos" => "Sandoval Almengor"
            ]
            2 => array:2 [
              "nombre" => "L&#46;A&#46;"
              "apellidos" => "D&#237;az Caballero"
            ]
            3 => array:2 [
              "nombre" => "J&#46;C&#46;"
              "apellidos" => "Salgado Campo"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572711000087?idApp=WMIE"
    "url" => "/21735727/0000003500000005/v2_201212101038/S2173572711000087/v2_201212101038/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S2173572711000063"
    "issn" => "21735727"
    "doi" => "10.1016/j.medine.2011.03.002"
    "estado" => "S300"
    "fechaPublicacion" => "2011-06-01"
    "aid" => "279"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46; and SEMICYUC"
    "documento" => "article"
    "crossmark" => 0
    "subdocumento" => "fla"
    "cita" => "Med Intensiva. 2011;35:280-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2482
      "formatos" => array:3 [
        "EPUB" => 125
        "HTML" => 1655
        "PDF" => 702
      ]
    ]
    "en" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Original</span>"
      "titulo" => "Prediction of the Clinical Usefulness of Routine Chest X-rays in a Traumatology ICU"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "280"
          "paginaFinal" => "285"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Predicci&#243;n de la utilidad cl&#237;nica de la radiograf&#237;a de t&#243;rax rutinaria en una unidad de cuidados intensivos de traumatolog&#237;a"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "M&#46; Chico Fern&#225;ndez, A&#46; Mohedano G&#243;mez, C&#46; Garc&#237;a-Fuentes, P&#46; Rico Cepeda, A&#46; Bueno Gonz&#225;lez, E&#46; Alted L&#243;pez"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "M&#46;"
              "apellidos" => "Chico Fern&#225;ndez"
            ]
            1 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Mohedano G&#243;mez"
            ]
            2 => array:2 [
              "nombre" => "C&#46;"
              "apellidos" => "Garc&#237;a-Fuentes"
            ]
            3 => array:2 [
              "nombre" => "P&#46;"
              "apellidos" => "Rico Cepeda"
            ]
            4 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Bueno Gonz&#225;lez"
            ]
            5 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Alted L&#243;pez"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572711000063?idApp=WMIE"
    "url" => "/21735727/0000003500000005/v2_201212101038/S2173572711000063/v2_201212101038/en/main.assets"
  ]
  "en" => array:18 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Point of view</span>"
    "titulo" => "Tranexamic Acid Therapy Decreases Mortality of Traumatic Hemorrhagic Shock"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "286"
        "paginaFinal" => "287"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "A&#46; Mu&#241;oz-S&#225;nchez, F&#46; Murillo-Cabezas"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "A&#46;"
            "apellidos" => "Mu&#241;oz-S&#225;nchez"
            "email" => array:1 [
              0 => "angeles&#46;munoz&#46;sspa&#64;juntadeandalucia&#46;es"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">¿</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "F&#46;"
            "apellidos" => "Murillo-Cabezas"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:1 [
            "entidad" => "Cuidados Cr&#237;ticos y Urgencias&#44; Hospital Universitario Virgen del Roc&#237;o&#44; Sevilla&#44; Spain"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "El &#225;cido tranex&#225;mico disminuye la mortalidad del <span class="elsevierStyleItalic">shock</span> hemorr&#225;gico traum&#225;tico"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">The Lancet</span><a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> recently published a randomized&#44; controlled clinical trial&#44; which in our view may change the outcome of a serious condition&#58; traumatic hemorrhagic shock&#46; This was a high quality trial&#44; and thus contributed top class evidence&#46; The study was not characterized by commercial interests&#44; and the inclusion criteria were based on clinical judgments&#44; i&#46;e&#46;&#44; it offered maximum external validity&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">The investigators&#44; under the name CRASH 2 Trial Collaborators&#44; came from 274 hospitals in 40 countries&#44; and were able to complete an ambitious project involving the recruitment of about 20&#44;000 trauma patients &#40;specifically 20&#44;211&#41; with significant blood losses&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">The study compared the use of a low-cost antifibrinolytic agent &#40;tranexamic acid&#41; versus placebo&#44; in the context of a double-blind design&#46; The drug was administered early&#44; in the first 8<span class="elsevierStyleHsp" style=""></span>h after trauma&#44; at a dosage of 2<span class="elsevierStyleHsp" style=""></span>g via the intravenous route&#44; a 1<span class="elsevierStyleHsp" style=""></span>g bolus initially&#44; and 1<span class="elsevierStyleHsp" style=""></span>g in perfusion over 8<span class="elsevierStyleHsp" style=""></span>h&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The trial methodology had been previously published in <span class="elsevierStyleItalic">The Lancet</span>&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> The primary endpoint was mortality of any cause during the first four weeks&#46; The losses during follow-up were minimal&#58; 33 patients in the active treatment group and 47 in the placebo arm&#46; The statistical analysis was carried out on an intention to treat &#40;ITT&#41; basis&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Global mortality&#44; not the only mortality associated to bleeding&#44; was significantly lowered in the tranexamic acid group &#40;<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>&#60;<span class="elsevierStyleHsp" style=""></span>0&#46;0035&#41;&#46; The incidence of occlusive vascular events&#44; fatal or otherwise&#44; was similar in both groups &#40;placebo and tranexamic acid&#41;&#46; Surprisingly&#44; no significant difference was recorded in the number of red cell concentrate units transfused in either group&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">Since the two study arms proved homogeneous in that they were balanced for multiple clinical risk parameters &#40;age&#44; gender&#44; time from trauma&#44; type of trauma&#44; systolic blood pressure upon admission&#44; respiratory frequency&#44; capillary filling time&#44; heart rate and level of consciousness according to the Glasgow coma scale&#41;&#44; and the breaches in protocol were identical in each arm &#40;0&#46;4&#37;&#41;&#44; the early administration of tranexamic acid was identified as a first-order therapeutic option thanks to its impact upon the most relevant medical variable&#58; patient mortality&#46; In addition&#44; given the low cost of tranexamic acid&#44; the use of only 81&#46;6 euros in treating 68 patients would allow the avoidance of one death in this group of patients&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">The study has some limitations&#8212;the most important being the fact that the trial does not clarify the mechanism by which tranexamic acid reduces mortality among patients with traumatic hemorrhage&#46; In fact&#44; not only bleeding-dependent mortality decreases&#44; but also global mortality among the trauma patients&#46; Thus&#44; the comment accompanying the article<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> suggests that a plasmin-mediated antiinflammatory effect may be involved&#46; A second study limitation would be the fact that the posology had not been previously tested in a phase II setting with this particular treatment indication&#46; In any case&#44; the dosage employed was consistent with the specifications of the Summary of Product Characteristics&#44; and with the data obtained from studies in heart surgery and other indications&#44; where no increased effectiveness was observed with higher doses&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Some years ago&#44; in this same journal&#44; we asked ourselves what could be done to improve the results obtained in serious trauma cases&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> At the time we did not suspect that an old drug such as tranexamic acid&#8211;with an accessible price anywhere in the world&#8211;could offer a positive response in the arduous attempt to lessen mortality among such patients&#46;</p><p id="par0045" class="elsevierStylePara elsevierViewall">In conclusion&#44; given the results obtained&#44; the large number of traumatic bleeding deaths recorded worldwide&#44; and the efficiency of tranexamic acid&#44; we have supported the application to include this drug in the list of essential medicines of the World Health Organization &#40;WHO&#41;&#46; In our setting&#44; and from June 2010&#44; the Drug Commission has authorized the compassionate use of tranexamic acid in traumatic hemorrhagic shock patients treated in our hospital&#46; Until the drug company includes this treatment indication in the Summary of Product Characteristics&#44; we consider compassionate use to be the fastest way to make this drug available to patients with a view to improving the outcome of trauma cases involving significant blood losses&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflicts of Interest</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:6 [
        0 => array:2 [
          "identificador" => "xres9181"
          "titulo" => "Abstract"
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec10621"
          "titulo" => "Keywords"
        ]
        2 => array:2 [
          "identificador" => "xres9180"
          "titulo" => "Resumen"
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec10620"
          "titulo" => "Palabras clave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Conflicts of Interest"
        ]
        5 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2011-01-13"
    "fechaAceptado" => "2011-01-18"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec10621"
          "palabras" => array:3 [
            0 => "Tranexamic acid"
            1 => "Traumatism"
            2 => "Traumatic bleeding shock"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec10620"
          "palabras" => array:3 [
            0 => "&#193;cido tranex&#225;mico"
            1 => "Traumatismo"
            2 => "<span class="elsevierStyleItalic">Shock</span> hemorr&#225;gico traum&#225;tico"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The CRASH 2&#44; a randomized&#44; double-blind&#44; controlled trial that enrolled 20&#44;211 adult trauma patients&#44; has shown that the administration of tranexamic acid significantly reduces all-cause mortality and that specifically associated with severe blood loss as well&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">We consider it as a significant therapeutic advance&#44; because&#44; for the first time&#44; a drug has been demonstrated to safely diminish mortality due to traumatic bleeding shock&#46; On the basis of these results and the high rate of death due to traumatic bleeding&#44; we suggest that tranexamic acid should be considered for compassionate use in bleeding trauma patients prior to its definitive approval for this medical condition&#46;</p>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Un estudio aleatorizado&#44; controlado con placebo y doble ciego&#44; el CRASH 2&#44; ha concluido&#44; tras incluir a 20&#46;211 traumatizados&#44; que el &#225;cido tranex&#225;mico reduce significativamente la mortalidad&#44; tanto la global como la espec&#237;ficamente ligada a la perdida sangu&#237;nea severa&#46;</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Consideramos que este es un avance terap&#233;utico significativo&#44; ya que por primera vez un f&#225;rmaco se ha mostrado capaz de disminuir la letalidad del <span class="elsevierStyleItalic">shock</span> hemorr&#225;gico traum&#225;tico&#46; Dados los resultados&#44; el elevado volumen de muertes por sangrado traum&#225;tico que se producen en el mundo y la eficiencia del tranex&#225;mico&#44; proponemos su uso compasivo hasta la inclusi&#243;n de esta indicaci&#243;n en la ficha t&#233;cnica&#46;</p>"
      ]
    ]
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara">Please cite this article as&#58; Mu&#241;oz-S&#225;nchez A&#44; Murillo-Cabezas F&#46; El &#225;cido tranex&#225;mico disminuye la mortalidad del <span class="elsevierStyleItalic">shock</span> hemorr&#225;gico traum&#225;tico&#46; Med Intensiva&#46; 2011&#59;35&#58;286&#8211;7&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:4 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Effects of tranex&#225;mico acid on death&#44; vascular occlusive events&#44; and blood transfusion in trauma patients with significant haemorrhage &#40;CRASH-2&#41;&#58; a randomised&#44; placebo-controlled trial"
                      "autores" => array:1 [
                        0 => array:3 [
                          "colaboracion" => "CRASH 2 Trial Collaborators"
                          "etal" => true
                          "autores" => array:3 [
                            0 => "H&#46; Shakur"
                            1 => "I&#46; Roberts"
                            2 => "R&#46; Bautista"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)60835-5"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2010"
                        "volumen" => "376"
                        "paginaInicial" => "23"
                        "paginaFinal" => "32"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20554319"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "CRASH2 Protocol&#46; 2005&#46; Available from&#58; <a class="elsevierStyleInterRef" href="http://www.thelancet.com/protocol-reviews/05PRT-1">http&#58;&#47;&#47;www&#46;thelancet&#46;com&#47;protocol-reviews&#47;05PRT-1</a>&#46;"
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Antifibrinolytic therapy&#58; new data and new concepts"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46;H&#46; Levy"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0140-6736(10)60939-7"
                      "Revista" => array:6 [
                        "tituloSerie" => "Lancet"
                        "fecha" => "2010"
                        "volumen" => "376"
                        "paginaInicial" => "3"
                        "paginaFinal" => "4"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20554318"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Qu&#233; podr&#237;amos hacer para mejorar los resultados en el traumatizado grave&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "F&#46; Murillo-Cabezas"
                            1 => "M&#46;A&#46; Mu&#241;oz-S&#225;nchez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Intensiva"
                        "fecha" => "2003"
                        "volumen" => "27"
                        "paginaInicial" => "669"
                        "paginaFinal" => "672"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21735727/0000003500000005/v2_201212101038/S217357271100004X/v2_201212101038/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "402"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Point of view"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21735727/0000003500000005/v2_201212101038/S217357271100004X/v2_201212101038/en/main.pdf?idApp=WMIE&text.app=https://medintensiva.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S217357271100004X?idApp=WMIE"
]
Article information
ISSN: 21735727
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 4 11 15
2024 October 62 48 110
2024 September 66 42 108
2024 August 74 57 131
2024 July 47 43 90
2024 June 56 42 98
2024 May 40 44 84
2024 April 48 41 89
2024 March 41 34 75
2024 February 36 61 97
2024 January 37 51 88
2023 December 33 48 81
2023 November 44 43 87
2023 October 52 41 93
2023 September 35 39 74
2023 August 30 15 45
2023 July 36 28 64
2023 June 39 16 55
2023 May 25 13 38
Show all

Follow this link to access the full text of the article

Idiomas
Medicina Intensiva (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?